EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Australasia

PCI and CSP Technologies, Inc. Announce Strategic Collaboration for Breakthrough Activ-BlisterTM Solutions

In scavenging for undesired moisture and gases, protective packaging solution enables enhanced shelf life and speed-to-market for pharmaceutical and medical device pr...
Continue Reading →
Australasia

Study finds daily aspirin does not reduce heart attack risk

Daily, low dose asprin found to not minimise heart attack risk. Monash University in Australia has repo...
Continue Reading →
Asia Pacific

HUJI gets an ultra-high resolution U-CT system

The researchers at Blum Lab will be using the MILabs’ ultra-high resolution CT to detect novel gold labeled probes in cancerous tissue as well as in atherosclerotic p...
Continue Reading →
Australasia

Marken Opens Clinical Trial Logistics Hub In Melbourne, Australia

Marken announced today the opening of a new branch located in Melbourne. The new location joins Sydney and Brisbane as the third Australian hub and solidifies the com...
Continue Reading →
Australasia

First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for Parkinsonian Diseases

Prana enrols and doses its first cohort of healthy volunteers in its Phase I clinical trial Evidence supports activity of PBT434 to prevent α-synuclein accumulat...
Continue Reading →
Australasia

Bionomics begins phase II clinical trial of drug for treating agitation

No approved treatments currently available for agitation Bionomics will recruit about 40 elderly patients in ...
Continue Reading →
Australasia

Australia NHMRC Clinical Trials Centre Partners with Medidata to Digitize Cancer Research

Medidata (NASDAQ: MDSO) announced that the National Health and Medical Research Council Clinical Trial Centre (NHMRC CTC), University of Sydney, will now use Medidata...
Continue Reading →
Australasia

Kerry Corning initiates phase 1 trial for narcoleptic drug

XW Laboratories Inc. has launched the first human body for the new narcoleptic drug XW10172 in Australia Phase I clinical trials to assess its safety, human tolerance...
Continue Reading →
Australasia

Australian scientists to develop blood test for lung cancer

The biomarker is expected to aid in predicting patients who would potentially respond to anti-PD-1 and anti-CTLA-4 immunotherapies. [caption id="" align="alignleft" w...
Continue Reading →
Australasia

New research looks to reduce side effects in commonly used drugs

New research from The Australian National University (ANU) has drilled down to the molecular level to find similarities across six pharmaceutical drugs used in pain r...
Continue Reading →
Catalyst: 12th January 2026
Quotient